Research report: Nutritional modulation of microbiome proteomics in insulin resistance

A literature review concludes that the functional activity of the gut microbiome, measured through microbial and host proteins rather than taxonomic lists alone, may help explain why people exposed to the same diet can show different metabolic responses. The authors argue that nutritional metaproteomics could eventually support more individualized approaches to insulin resistance, but they emphasize that most of the proposed mechanisms remain correlational or preclinical and require extensive validation in humans. Their synthesis draws on human studies, animal experiments, cell-based work and protocol studies published since 2010, with evidence ranked according to study design and consistency.

Insulin resistance is a central metabolic abnormality associated with type 2 diabetes, obesity and gestational diabetes, yet the review presents it as a systemic condition shaped by interactions among diet, microbial function and the host proteome rather than by a single organ, nutrient or microbial species. Proteins are the primary functional units of cells, and their abundance, modification and secretion can differ from what gene-expression measurements alone predict. Proteomics therefore offers a more direct view of cellular activity, including changes in mitochondrial oxidation, inflammation, oxidative stress and insulin signaling that may be missed by transcriptomic surveys.

This distinction is central to the review’s proposal that functional pathways, rather than taxonomic composition alone, should guide efforts to understand metabolic health. Skeletal muscle is especially relevant because the review states that it accounts for approximately 80% of insulin-stimulated glucose disposal. Evidence drawn largely from preclinical models and early-stage human investigations associates insulin resistance with reduced abundance of mitochondrial oxidation proteins and altered phosphorylation of complexes associated with ATP synthase.

These changes could impair cellular energy metabolism and potentially weaken insulin-signaling pathways. Reviews of obesity also report higher levels of proteins linked to inflammation and oxidative stress, including complement C3 and catalase, while proteomic meta-analyses in gestational diabetes have identified 262 candidate biomarkers, with prominent links to complement and coagulation pathways. The findings identify candidate mechanisms and markers rather than establishing a clinical test or treatment.

At the microbial end, metaproteomics identifies the proteins actually expressed by a gut community. Whereas 16S ribosomal RNA sequencing mainly indicates which organisms are present and their broad metabolic potential, metaproteomics captures active reactions under particular conditions, including exposure to diet, inflammation or medication. In insulin resistance and type 2 diabetes, the reviewed literature points to increased microbial representation of enzymes involved in starch and pectin processing, including beta-glucosidase and pectate lyase.

This pattern is consistent with greater fermentation of carbohydrates that may not otherwise be absorbed by the host, although the review does not establish that these enzymes alone cause metabolic dysfunction. The distinction between microbial potential and measured activity is one reason the authors argue for a nutrition-centered metaproteomic framework. Differences in the abundance of bacterial proteins may also influence the production of short-chain fatty acids and other metabolites that communicate with host tissues.

Butyryl-CoA dehydrogenase, for example, has been differentially expressed in insulin-resistant states in the evidence summarized by the authors, raising the possibility of effects on pathways such as PI3K and Akt. Childhood obesity and insulin-resistance studies further link reduced abundance of Akkermansia muciniphila with lower levels of circulating host proteins, including IGFBP1 and GP6, that participate in metabolic and immune functions. The metaproteome can also track disruption of the intestinal barrier through host structural proteins such as mucin-2 and immunoglobulin polypeptides associated with inflammation and permeability.

These observations are relevant to host–microbiome communication, but the review treats many of the individual associations as preliminary. Host–microbiome protein communication provides a mechanistic bridge between diet and insulin action, although the strength of the evidence varies considerably across proposed links. Recent host-focused analyses have annotated commensal bacterial proteins with links to human immune, endocrine, apoptotic and cancer-related pathways.

In vitro work reviewed by the authors found that type III secretion effectors from human-gut Pseudomonadota could enter human cells and alter nuclear factor kappa B signaling and cytokine secretion. Such findings show that microbial proteins can modify host molecular networks, but the evidence remains largely mechanistic or preclinical. The clearest protein-level connections to insulin resistance discussed in the review run through innate immune sensing, gut-barrier integrity and short-chain-fatty-acid receptor signaling rather than through a large catalogue of individually named microbial–human protein pairs.

Evidence also points to a bidirectional relationship between insulin signaling and the gut environment. Preliminary animal findings suggest that acute insulin resistance can itself increase gut permeability, disturb the microbiota and weaken antimicrobial defenses, indicating that insulin signaling may act as a gatekeeper of intestinal barrier integrity. Short-chain fatty acids provide another route between diet, microbes and host metabolism: in mice, the receptor GPR43 senses these microbial products and regulates adipose-tissue insulin signaling.

Together, these observations suggest a signaling web rather than one linear route. Nutrients alter microbial metabolism, microbial metabolites engage host receptors, and the resulting signals may influence insulin action in the intestine, liver, adipose tissue and skeletal muscle. However, most relationships beyond the GPR43–short-chain-fatty-acid axis remain dependent on animal models, as the review notes.

The review’s broader analysis also identifies a potential functional signature of insulin-resistant dysbiosis. Reanalysis of ten fecal metaproteomic datasets from healthy people revealed a proposed core metaproteome containing 182 shared microbial functions and 83 metabolic pathways, suggesting that a functional layer can persist despite variation in community composition. In parallel, human multi-omics research has associated elevated fecal monosaccharides in insulin-resistant participants with microbial carbohydrate metabolism and host inflammatory cytokines.

The authors interpret these findings as a possible “energy surplus” state involving both the microbiome and the host, but the supplied evidence does not identify the design of the multi-omics study or establish the direction of the relationships. The associations therefore cannot demonstrate that microbial carbohydrate processing causes either elevated fecal monosaccharides or insulin resistance. Translation of these signals into nutrition practice is constrained by substantial technical and study-design limitations.

Diet, medication and microbial diversity influence gut and fecal samples, while differences in storage, protein extraction and peptide preparation can alter the recovery of microbial proteins. Host proteins often predominate in gastrointestinal specimens and can obscure low-abundance microbial enzymes linked to glucose metabolism, inflammation or insulin signaling. Taxonomic differences and uneven extraction across cellular compartments introduce further bias.

Incomplete reference databases also complicate identification of proteins from poorly characterized gut organisms, while divergent bioinformatics pipelines weaken reproducibility. Nutritional interventions additionally suffer from short follow-up, inconsistent dietary assessment and incomplete control of obesity, physical activity and medication use. These limitations make it difficult to determine whether a detected protein is a reproducible biomarker, a response to diet or an artifact of sample processing.

The authors consequently present a metagenome-informed, nutrition-centered metaproteomic framework as a research direction rather than an established clinical tool. Their priorities include longitudinal sampling before and after dietary interventions in human cohorts, direct validation of microbial protein–host receptor interactions in human tissues, and individual-level integration of metaproteomic, metagenomic and metabolomic data to model dietary response. Combining these measurements with host inflammatory markers may eventually help identify people whose microbial functions predict a metabolic response to a specified diet.

Until then, the reviewed evidence supports biological plausibility and promising analytical tools, not a validated test for insulin resistance, a proven dietary protocol or a demonstrated clinical benefit. The central implication is that personalized nutrition may need to account for active microbial pathways as well as organisms, diet and host biology, with rigorous longitudinal studies needed to determine when that approach can move from a conceptual framework into practice.

Subject of Research: Nutritional metaproteomics for understanding diet-linked microbial and host proteins in insulin resistance

Article Title: Nutritional modulation of microbiome proteomics in insulin resistance

Article References: Dener, B., Gülal, S. İ., Bulut, M., Hızlı-Güldemir, H., Raposa, B., & Aǧagündüz, D. (2026). Nutritional modulation of microbiome proteomics in insulin resistance. Frontiers in Nutrition, 13, Article 1913314. https://doi.org/10.3389/fnut.2026.1913314

Image Credits: AI Generated

DOI: 10.3389/fnut.2026.1913314

Keywords: insulin resistance, gut microbiome, metaproteomics, proteomics, nutrition, short-chain fatty acids, host–microbiome crosstalk, gut barrier, precision nutrition, microbial proteins, Nutritional, modulation